Breast Disorders

65 questions

Question 1Question →

Match each clinical presentation of a breast disorder to the most appropriate initial diagnostic workup or management step.

Click a left item, then click its matching right item

Items

22-year-old woman with a newly discovered 2-cm firm, mobile, well-circumscribed palpable breast mass
32-year-old woman with bilateral, multi-ductal milky nipple discharge and no palpable breast masses
45-year-old woman with a new 3-cm firm, poorly circumscribed, painless palpable breast mass
26-year-old exclusively breastfeeding woman with fever, localized breast erythema, and a fluctuant, tender 4-cm mass

Matches

Show answer & explanation

Answer

Left 1 matches with Targeted breast ultrasound; Left 2 matches with Serum prolactin, TSH, and pregnancy testing; Left 3 matches with Diagnostic mammography and targeted breast ultrasound; Left 4 matches with Needle aspiration and empiric antibiotic therapy.
Each clinical scenario corresponds to a specific, guideline-directed management pathway based on age, symptom characteristics, and reproductive status.

Step-by-Step Solution

1
Evaluate the 22-year-old patient with a palpable breast mass.
Determine that the patient's age (< 30 years) necessitates targeted breast ultrasound as the first-line imaging.
Dense breast tissue in younger women lowers mammographic sensitivity and increases radiation risks, making ultrasound the standard initial test.
2
Assess the 32-year-old patient with milky nipple discharge.
Recognize this as physiologic galactorrhea, requiring endocrine evaluation before any imaging.
Bilateral, multiductal, milky discharge without a mass is rarely malignant and is typically driven by hormonal abnormalities.
3
Evaluate the 45-year-old patient with a palpable breast mass.
Select diagnostic mammography and targeted breast ultrasound.
For women aged 30 and older, both modalities are used to fully characterize the mass and screen for synchronous lesions in the ipsilateral or contralateral breast.
4
Evaluate the 26-year-old breastfeeding patient with a fluctuant mass and fever.
Identify a breast abscess and select needle aspiration with empiric antibiotics.
A localized, fluctuant collection in the setting of mastitis indicates an abscess that must be mechanically drained and treated with antibiotics targeting skin flora.

Key Concept

The initial evaluation of breast symptoms strictly depends on patient age (ultrasound for <30 vs. mammogram + ultrasound for >=30), the physiologic vs. pathologic nature of nipple discharge, and identifying signs of localized infection requiring drainage.
Question 2Question →

A 40-year-old woman asks about her future risk of developing breast cancer after undergoing a core needle biopsy for a mammographic abnormality. Arrange the following potential histopathologic biopsy results in order from the LOWEST to the HIGHEST risk for the subsequent development of invasive breast cancer.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence from lowest to highest risk is: Simple breast cyst, Intraductal papilloma without atypia, Atypical ductal hyperplasia, and Ductal carcinoma in situ.
Breast pathology findings are clinically classified by their associated risk for the subsequent development of invasive breast cancer. Nonproliferative lesions (e.g., simple cysts, mild hyperplasia, simple fibroadenomas) do not elevate this risk above that of the general population. Proliferative lesions without atypia (e.g., intraductal papillomas, complex fibroadenomas, moderate or florid hyperplasia, sclerosing adenosis) convey a slightly increased relative risk. Proliferative lesions with atypia (e.g., atypical ductal or lobular hyperplasia) carry a moderately increased relative risk, warranting closer surveillance. Finally, carcinoma in situ (e.g., ductal carcinoma in situ) is considered a pre-malignant lesion with the highest relative risk of progression to invasive disease among these categories.

Step-by-Step Solution

1
Identify the risk associated with nonproliferative lesions.
Simple breast cysts carry no increased relative risk.
These are benign fluid-filled spaces without cellular proliferation.
2
Identify the risk associated with proliferative lesions without atypia.
Intraductal papilloma without atypia has a slightly increased relative risk (approximately 1.5 to 2.0).
There is cellular proliferation within the duct, but no abnormal or atypical cellular changes are present.
3
Identify the risk associated with proliferative lesions with atypia.
Atypical ductal hyperplasia has a moderately increased relative risk (approximately 4.0 to 5.0).
There is cellular proliferation featuring abnormal cellular characteristics that do not yet meet the full criteria for carcinoma in situ.
4
Identify the risk associated with carcinoma in situ.
Ductal carcinoma in situ has the highest relative risk among these options (approximately 8.0 to 10.0).
It represents malignant epithelial cells that are contained strictly within the ductal basement membrane, which can directly progress to invasive carcinoma.

Key Concept

Breast pathology findings are stratified by their future risk of invasive breast cancer: nonproliferative (no increased risk), proliferative without atypia (slight increase), proliferative with atypia (moderate increase), and carcinoma in situ (high risk).
Question 3Question →

A 26-year-old woman, G1P0 at 14 weeks gestation, presents to the clinic after finding a lump in her right breast. She first noticed the lump one month ago, and it has not changed in size. She reports no nipple discharge, overlying skin changes, or breast pain. Family history is notable for a maternal aunt diagnosed with breast cancer at age 52. Vital signs are within normal limits. Physical examination reveals a 3.5-cm, firm, non-tender, fixed mass in the upper outer quadrant of the right breast. A firm 1.5-cm lymph node is palpable in the right axilla. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Targeted ultrasound of the right breast

Answer

Targeted ultrasound of the right breast is the most appropriate next step.
The correct answer is targeted ultrasound of the breast. When evaluating a palpable breast mass, the initial step strictly depends on the patient's age and pregnancy status. For women under 30 years of age, as well as pregnant or lactating patients, targeted ultrasound is the first-line diagnostic test. This is because these demographics have highly dense glandular breast tissue, which drastically reduces the sensitivity of traditional mammography. This patient is 26 years old and pregnant. Although her physical exam findings (fixed mass, axillary lymphadenopathy) are highly concerning for breast cancer and she will certainly require a core needle biopsy for definitive tissue diagnosis, imaging must always be performed first. Ultrasound characterizes the mass, assesses for additional non-palpable lesions, maps the axillary lymph nodes, and serves as an essential real-time guide for the subsequent core needle biopsy.

Step-by-Step Solution

1
Identify the primary clinical problem and patient demographic.
The patient is a 26-year-old pregnant woman presenting with a highly suspicious palpable breast mass (firm, fixed) and ipsilateral axillary lymphadenopathy.
Patient age, pregnancy status, and physical exam findings dictate the strict algorithmic approach to a breast mass.
2
Apply the age-based diagnostic pathway for palpable breast masses.
For patients under 30 years old, or pregnant/lactating patients, targeted breast ultrasound is the required initial diagnostic step.
Dense breast tissue in young and pregnant populations severely limits the sensitivity of mammography. Ultrasound effectively distinguishes solid from cystic lesions without ionizing radiation.
3
Determine if highly suspicious physical exam findings bypass the need for initial imaging.
They do not. Despite the presence of 'red flag' signs that warrant eventual tissue diagnosis, imaging must always precede biopsy.
Imaging is mandatory to fully characterize the primary lesion, evaluate for multifocal or multicentric disease, assess regional lymph nodes, and provide real-time guidance for a subsequent core needle biopsy.

Key Concept

In patients under 30 years of age and in pregnant or lactating women, targeted breast ultrasound is the initial modality of choice for evaluating a palpable breast mass, even when clinical features strongly suggest malignancy and eventual biopsy is inevitable.
Estimated Time:1m 0s
Question 4Question →

A 48-year-old woman comes to the clinic due to a 3-week history of right breast swelling, redness, and heaviness. She is not pregnant and has not lactated in over 15 years. Two weeks ago, she was evaluated at an urgent care clinic for these symptoms, diagnosed with mastitis, and prescribed a 10-day course of oral cephalexin. She completed the antibiotics, but her symptoms have progressively worsened. Her temperature is 37.1°C (98.8°F). Physical examination of the right breast reveals diffuse erythema and significant edema over 60% of the breast surface. The skin has a thickened, pitted appearance resembling an orange peel. Palpation reveals generalized firmness without a discrete, fluctuant mass. There is palpable, firm right axillary lymphadenopathy. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Diagnostic imaging and core needle biopsy

Answer

Diagnostic imaging and core needle biopsy
The correct answer identifies the need for urgent diagnostic workup. This patient's presentation of rapid-onset breast erythema, edema, and peau d'orange (pitted, orange-peel appearance of the skin) that fails to improve with a standard course of antibiotics is highly suspicious for inflammatory breast cancer (IBC). IBC is an aggressive form of primary breast carcinoma characterized by tumor emboli obstructing dermal lymphatic channels, which causes the classic edematous skin changes. When a non-lactating woman presents with symptoms of mastitis that do not resolve with appropriate antibiotic therapy, malignancy must be immediately ruled out. The most appropriate next step is diagnostic imaging (mammography and ultrasound) followed promptly by a core needle biopsy of the breast parenchyma and often a punch biopsy of the affected skin.

Step-by-Step Solution

1
Analyze the patient's demographic and clinical presentation.
A 48-year-old non-lactating woman presents with unilateral breast erythema, edema, and 'peau d'orange' skin changes.
Identifying the patient's age and lactational status helps differentiate between infectious mastitis (common in lactation) and other etiologies.
2
Evaluate the response to prior therapy.
The symptoms worsened despite a full 10-day course of appropriate oral antibiotics (cephalexin).
Failure to improve on antibiotics for presumed mastitis in a non-lactating woman is a classic red flag for underlying malignancy.
3
Identify the most likely diagnosis based on the physical exam findings.
The presence of peau d'orange and axillary lymphadenopathy points to Inflammatory Breast Cancer (IBC).
IBC causes dermal lymphatic obstruction by tumor emboli, leading to the characteristic pitted skin edema.
4
Determine the next best step in management for suspected Inflammatory Breast Cancer.
Diagnostic imaging (mammography and ultrasound) followed by core needle biopsy of the breast and a skin punch biopsy.
Histological confirmation is urgently required to diagnose IBC and initiate neoadjuvant chemotherapy.

Key Concept

Any non-lactating woman presenting with symptoms of mastitis that do not resolve with a standard course of antibiotics must be urgently evaluated for Inflammatory Breast Cancer using imaging and biopsy.
Question 5Question →

An evaluation is requested for a 38-year-old G2P2 woman presenting with progressive right breast enlargement and erythema over the past three weeks. She recently completed a 10-day course of cephalexin for a presumptive diagnosis of mastitis, but her symptoms have worsened. The patient is not pregnant and last breastfed 4 years ago. She has no personal or family history of cancer. Her temperature is 37.1°C (98.8°F), blood pressure is 122/78 mm Hg, and pulse is 76/min. Physical examination reveals a globally swollen, erythematous right breast with prominent skin dimpling and thickening over the dependent portion. A 5-cm firm, ill-defined area of induration is palpated deep to the areola. A 2-cm, hard, mobile lymph node is palpable in the right axilla. Arrange the following steps in the most appropriate sequential order for the diagnostic workup and management of this patient's most likely condition.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequential order for managing suspected inflammatory breast cancer is initial imaging (mammography and ultrasound), followed by diagnostic biopsies (core needle and skin punch), initiation of neoadjuvant chemotherapy, surgical resection via modified radical mastectomy, and finally, postmastectomy radiation therapy.
Inflammatory breast cancer (IBC) is a rare but highly aggressive form of locally advanced breast cancer characterized by rapid-onset erythema and edema (peau d'orange) resulting from tumor emboli in dermal lymphatics. When a patient presents with 'mastitis' that fails to respond to antibiotics, IBC must be strongly suspected. The management of IBC follows a strict, multidisciplinary sequential algorithm. First, bilateral mammography and targeted ultrasound delineate the extent of the disease and guide tissue sampling. Second, a definitive tissue diagnosis requires both a core needle biopsy of the underlying mass and a skin punch biopsy to confirm dermal lymphatic invasion. Because IBC is considered locally advanced (clinical Stage III) at presentation, primary surgery is contraindicated as negative surgical margins cannot be reliably achieved. Therefore, the third step is neoadjuvant (preoperative) systemic chemotherapy to downstage the tumor and treat micrometastatic disease. After chemotherapy, the fourth step is surgical consolidation. Due to diffuse skin and lymphatic involvement, breast-conserving therapy (lumpectomy) is inappropriate, and a modified radical mastectomy is performed. Finally, the fifth step is adjuvant postmastectomy radiation therapy directed at the chest wall and regional nodes to reduce the inherently high risk of locoregional recurrence.

Step-by-Step Solution

1
Identify the most likely diagnosis based on the clinical presentation.
Inflammatory breast cancer (IBC).
The patient presents with rapid-onset breast erythema, edema (peau d'orange), and a palpable mass that did not resolve with antibiotics, which is the classic presentation of IBC rather than infectious mastitis.
2
Determine the initial diagnostic approach.
Diagnostic mammography and targeted ultrasound.
Standard imaging is always the first step to evaluate the extent of the breast mass and assess axillary lymph nodes before invasive procedures.
3
Identify the specific biopsy requirements for this diagnosis.
Core needle biopsy of the mass AND skin punch biopsy.
Tissue diagnosis is required. A skin punch biopsy is uniquely necessary in IBC to identify malignant cells in the dermal lymphatics, confirming the clinical diagnosis.
4
Determine the primary sequence of oncologic treatment for IBC.
Neoadjuvant chemotherapy, followed by modified radical mastectomy, followed by radiation.
IBC is locally advanced at presentation. To achieve surgical clearance and treat systemic micrometastases, induction (neoadjuvant) chemotherapy must precede surgery. Breast conservation is contraindicated, making mastectomy necessary, followed by radiation to prevent local recurrence.

Key Concept

Diagnostic and therapeutic algorithm for Inflammatory Breast Cancer
Question 6Question →

A 54-year-old postmenopausal woman comes to the clinic due to a 3-month history of an itchy, flaking rash on her left nipple and areola. She states that the rash initially began as a small red patch but has gradually spread and thickened. She applied an over-the-counter hydrocortisone cream twice daily for 4 weeks with no improvement. She has no personal or family history of breast cancer. On physical examination, there is a unilateral, well-demarcated, erythematous, scaly plaque confined to the left nipple-areolar complex with small areas of superficial crusting and ulceration. The nipple appears slightly flattened. Palpation of the left breast yields no distinct masses. Axillary lymph nodes are not palpable. Bilateral diagnostic mammography reveals no abnormalities. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Punch biopsy of the skin lesion

Answer

Punch biopsy of the skin lesion is the most appropriate next step to diagnose suspected Paget disease of the breast.
This patient presents with a unilateral, pruritic, scaly, and crusting erythematous plaque on the nipple-areolar complex that is refractory to low-potency topical corticosteroids. This presentation is highly suspicious for Paget disease of the breast, a rare malignancy characterized by the migration of malignant glandular cells (Paget cells) through the lactiferous ducts to the nipple epidermis. The most appropriate next step in management is a full-thickness skin biopsy (such as a punch biopsy) of the affected area to establish a histopathologic diagnosis. Even with a negative mammogram and no palpable mass, biopsy is mandatory because a significant percentage of patients with Paget disease have an underlying ductal carcinoma in situ (DCIS) or invasive carcinoma that is occult on mammography.

Step-by-Step Solution

1
Identify the key clinical features
Unilateral, persistent, pruritic and scaling nipple rash in a postmenopausal woman that is refractory to topical corticosteroids.
Differentiates malignant from benign etiology.
2
Determine the most likely diagnosis
Paget disease of the breast.
The failure of empirical treatment for a unilateral eczema-like lesion points toward a neoplastic process involving the nipple epidermis.
3
Select the most appropriate diagnostic test
Punch biopsy of the affected skin.
A full-thickness skin biopsy is required to identify intraepidermal Paget cells and establish the diagnosis, regardless of mammography findings.

Key Concept

Diagnosis of Paget disease of the breast requires a full-thickness skin biopsy (e.g., punch biopsy) of the affected nipple-areolar complex, especially when conservative therapy fails.
Estimated Time:1m 30s
Question 7Question →

A 24-year-old woman comes to the office after discovering a lump in her right breast while showering 3 days ago. She has not noticed any nipple discharge, skin changes, or breast pain. Her menstrual periods occur every 28 days and last for 4 to 5 days. Her last menstrual period ended 2 weeks ago. Her medical history is unremarkable, and she takes no medications. She has no family history of breast or ovarian cancer. Vital signs are within normal limits. On physical examination, there is a 2.5-cm, firm, mobile, non-tender, well-circumscribed mass in the upper outer quadrant of the right breast. There is no overlying skin erythema, dimpling, or nipple retraction. No axillary or supraclavicular lymphadenopathy is appreciated. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Targeted ultrasound of the right breast

Answer

Targeted ultrasound of the right breast
The correct approach for a new palpable breast mass in a woman younger than 30 years is to perform a targeted ultrasound. Ultrasound is the preferred initial imaging modality in this age group because young women typically have dense breast tissue, which significantly decreases the sensitivity of mammography. Ultrasound can reliably differentiate between solid masses (e.g., fibroadenomas, carcinomas) and fluid-filled simple cysts. If the ultrasound confirms a benign-appearing solid mass (like a fibroadenoma), the patient may then be managed with short-term follow-up or a core needle biopsy based on patient preference and specific ultrasound features.

Step-by-Step Solution

1
Identify the patient's age and clinical presentation.
The patient is a 24-year-old female with a new, distinct, palpable breast mass.
Age is the primary determinant for the initial choice of imaging modality in the diagnostic workup of breast masses.
2
Determine the appropriate initial diagnostic modality based on age.
For women younger than 30 years, targeted ultrasound is indicated.
Younger women have denser breast tissue, which makes mammography less sensitive. Ultrasound effectively differentiates solid masses from fluid-filled cysts.
3
Rule out premature or inappropriate interventions.
Biopsy, mammography, and simple reassurance without imaging are rejected.
Imaging must precede invasive tissue sampling, mammography is reserved for older patients initially, and all new palpable masses require at least baseline imaging evaluation.

Key Concept

Age-based diagnostic pathways for palpable breast masses
Question 8Question →

Evaluate the following clinical scenarios encountered in an outpatient women's health clinic. Select the most accurate diagnosis that corresponds to each patient's specific presentation.

Click a left item, then click its matching right item

Items

A 24-year-old nulliparous patient presenting with a 2-cm, firm, highly mobile, non-tender nodule; ultrasound demonstrates a well-circumscribed, solid, hypoechoic mass.
A 48-year-old perimenopausal patient presenting with cyclical bilateral breast pain and diffuse cord-like thickening that is most pronounced just prior to menstruation.
A 36-year-old patient presenting with spontaneous, bloody, unilateral nipple discharge; physical examination reveals no palpable breast masses or skin changes.
A 58-year-old postmenopausal patient presenting with a chronic, scaly, erythematous rash confined to the areola that oozes and has failed treatment with topical corticosteroids.

Matches

Show answer & explanation

Answer

The presentations match as follows: the young patient with a highly mobile solid mass has a Fibroadenoma; the perimenopausal patient with cyclical pain has Fibrocystic changes; the patient with isolated bloody nipple discharge has an Intraductal papilloma; and the postmenopausal patient with areolar eczema has Paget disease of the breast.
Each clinical vignette provides classic epidemiological and pathophysiological clues. Fibroadenomas present as mobile solid masses in younger women. Fibrocystic changes cause cyclical pain and nodularity in pre- and perimenopausal women. Intraductal papillomas cause spontaneous bloody discharge without a mass. Paget disease of the breast mimics areolar eczema in older women.

Step-by-Step Solution

1
Analyze the 24-year-old patient with a mobile solid mass.
The age and 'highly mobile' clinical characteristic point to a benign fibroadenoma.
Fibroadenomas are the most common benign breast tumors in women under 30 and typically present as well-circumscribed, mobile masses.
2
Assess the 48-year-old patient with cyclical pain and nodularity.
The timing of the pain relative to menses indicates fibrocystic changes.
Hormonal fluctuations cause these benign physiologic changes to become symptomatic, usually worsening just prior to menstruation.
3
Evaluate the 36-year-old patient with unilateral bloody discharge.
The lack of a palpable mass combined with spontaneous bloody discharge isolates intraductal papilloma as the primary suspect.
Intraductal papillomas arise from the ductal epithelium and are the most common cause of pathologic bloody nipple discharge.
4
Review the 58-year-old patient with a refractory areolar rash.
The eczematous changes refractory to topical steroids point to Paget disease of the breast.
Paget disease is characterized by malignant intraepithelial cells spreading to the nipple and areolar skin, initially mimicking eczema.

Key Concept

Differentiating benign and malignant breast pathology based on patient age, physical examination findings, and symptom cyclicity.
Question 9Question →

An otherwise healthy 36-year-old female patient presents to the outpatient clinic reporting a 3-week history of spontaneous, unilateral breast discharge. She notes finding small, blood-stained spots on the inside of her bra on the left side. The patient denies any localized breast pain, fever, recent trauma, or palpable lumps. Her menstrual cycles are regular, and she is currently nulliparous. She takes no daily medications and has no family history of breast cancer. On physical examination, visual inspection shows normal breast symmetry without overlying skin changes or nipple retraction. Careful palpation of all quadrants yields no discrete masses, and there is no axillary lymphadenopathy. Gentle pressure applied around the left areola produces a single drop of bloody fluid from a single duct opening. Which of the following is the most likely diagnosis?

Show answer & explanation

Answer: Intraductal papilloma

Answer

Intraductal papilloma
The correct answer is intraductal papilloma, which is a benign tumor that grows within the large lactiferous ducts of the breast beneath the areola. Because these lesions are highly vascular and fragile, they commonly present with spontaneous, unilateral, bloody or serosanguineous nipple discharge, characteristically from a single duct opening. Unless the papilloma is unusually large or located very superficially, it typically does not present with an associated palpable breast mass or overlying skin changes. The patient's presentation is the textbook description of this benign pathology.

Step-by-Step Solution

1
Analyze the patient's primary symptom.
The patient has spontaneous, unilateral, bloody discharge originating from a single duct on the left breast.
Characterizing the nature (bloody vs. milky), laterality (unilateral vs. bilateral), and spontaneity of the discharge narrows the differential diagnosis.
2
Evaluate the associated physical examination findings.
There are no palpable breast masses, skin changes (such as dimpling or erythema), or signs of trauma.
The absence of a mass helps rule out etiologies like fat necrosis or large invasive carcinomas, pointing toward a small ductal lesion.
3
Synthesize findings to identify the most likely pathology.
A solitary, bloody discharge without a mass is the classic hallmark of an intraductal papilloma.
Intraductal papillomas are benign, fragile polypoid tumors within the lactiferous ducts that easily bleed, causing the exact presentation seen in this patient.

Key Concept

Intraductal papilloma is the most common cause of spontaneous, unilateral, bloody or serosanguineous nipple discharge in the absence of a palpable breast mass.
Estimated Time:50s
Question 10Question →

Match each clinical presentation of a breast disorder to its most likely corresponding histopathological finding on core needle biopsy.

Click a left item, then click its matching right item

Items

A 42-year-old woman presents with a 2-cm firm, irregular breast mass and skin retraction. She had a reduction mammoplasty 2 years ago. Mammography shows a spiculated mass with coarse calcifications.
A 54-year-old woman presents with a 6-cm firm, mobile, well-circumscribed breast mass that has doubled in size over the last 3 months.
A 38-year-old woman presents with spontaneous, unilateral, bloody nipple discharge. Examination reveals no palpable breast masses or axillary lymphadenopathy.
A 62-year-old woman presents with an intensely pruritic, erythematous, scaly lesion over the left nipple that has failed to improve with a 4-week course of topical hydrocortisone.

Matches

Show answer & explanation

Answer

Match the clinical presentations to their definitive histopathological features: Patient 1 (trauma/calcifications) has fat necrosis, Patient 2 (rapidly growing mass) has a phyllodes tumor, Patient 3 (bloody discharge) has an intraductal papilloma, and Patient 4 (steroid-refractory scaly nipple) has Paget disease of the breast.
Each clinical vignette uniquely maps to a single histopathological entity. Fat necrosis is linked to trauma and foamy macrophages. Phyllodes tumor presents as a rapidly enlarging mass with leaf-like stroma. Intraductal papilloma causes bloody discharge due to fibrovascular cores in a duct. Paget disease presents as an eczematous plaque containing intraepidermal malignant cells with clear halos.

Step-by-Step Solution

1
Analyze the presentation of Patient 1 (surgery history, skin retraction, coarse calcifications).
Diagnose fat necrosis.
Prior surgical trauma leads to fat necrosis, which can mimic malignancy clinically (skin retraction, spiculated mass) but shows lipid-laden macrophages and giant cells on biopsy.
2
Analyze the presentation of Patient 2 (54-year-old, rapidly enlarging 6-cm mobile mass).
Diagnose phyllodes tumor.
Rapid growth of a large, well-circumscribed mass in this age group points to a fibroepithelial lesion with cellular stroma and leaf-like architecture.
3
Analyze the presentation of Patient 3 (spontaneous, bloody nipple discharge without a mass).
Diagnose intraductal papilloma.
The most common cause of unilateral bloody discharge is a benign intraductal papilloma, defined by fibrovascular cores within a duct.
4
Analyze the presentation of Patient 4 (62-year-old, scaly nipple failing steroid therapy).
Diagnose Paget disease of the breast.
An eczematous-appearing nipple lesion that does not respond to topical therapy is Paget disease until proven otherwise, characterized by intraepidermal clear cells.

Key Concept

Clinicopathologic correlation of distinct breast disorders, distinguishing benign conditions, high-risk lesions, and malignancies based on age, presentation, and cellular architecture.
Question 11Question →

A 26-year-old nulligravid woman comes to the clinic because she found a lump in her left breast 1 week ago. She is premenopausal with regular 28-day menstrual cycles, and her last menstrual period was 10 days ago. She is currently not pregnant and is not lactating. She has no significant past medical history, and her family history is negative for breast or ovarian cancer. On physical examination, her vital signs are within normal limits. Breast examination reveals a 2.5-cm, firm, mobile, well-circumscribed, and non-tender mass in the upper outer quadrant of the left breast. There is no overlying skin dimpling, erythema, or nipple discharge. There is no palpable axillary or supraclavicular lymphadenopathy. Which of the following is the most appropriate next step in evaluation?

Show answer & explanation

Answer: Targeted ultrasound of the left breast

Answer

Targeted ultrasound of the left breast is the most appropriate next step.
The correct answer is targeted ultrasound of the left breast. In the clinical evaluation of a newly palpable breast mass, the patient's age dictates the initial imaging modality. For women under 30 years old, ultrasound is the first-line choice because their breast tissue is typically radiographically dense, which can obscure masses on mammography. Ultrasound can accurately differentiate between a simple cyst and a solid mass (e.g., fibroadenoma) and does not expose the patient to unnecessary ionizing radiation.

Step-by-Step Solution

1
Identify the patient's demographic risk factors and clinical presentation.
The patient is a 26-year-old female presenting with a newly palpable, discrete breast mass that is firm and mobile, characteristic of a benign lesion such as a fibroadenoma.
Patient age is the primary determinant for the initial imaging algorithm in evaluating a new breast mass.
2
Apply the standard age-based clinical guideline for breast mass evaluation.
For patients under 30 years of age, targeted ultrasound is the preferred initial imaging test.
Younger women have dense breast tissue that limits the diagnostic utility of mammography. Ultrasound effectively characterizes the mass (cystic versus solid) without ionizing radiation.

Key Concept

In evaluating a palpable breast mass in a woman under 30 years of age, targeted ultrasound is the first-line imaging modality due to dense breast tissue limiting the utility of mammography.
Estimated Time:1m 0s
Question 12Question →

A 54-year-old postmenopausal woman comes to the clinic to discuss the results of a recent breast biopsy. A routine screening mammogram performed two weeks ago demonstrated a new 8-mm cluster of fine, pleomorphic microcalcifications in the upper outer quadrant of her right breast. Physical examination reveals no palpable breast masses, nipple discharge, or overlying skin changes. Axillary lymph nodes are not palpable. She has no personal or family history of breast, ovarian, or colon cancer. She underwent a stereotactic core needle biopsy of the calcifications. The histopathology report reveals classic lobular carcinoma in situ (LCIS) without evidence of invasive disease or atypia. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Surgical excisional biopsy of the right breast lesion

Answer

Surgical excisional biopsy of the right breast lesion
The correct next step is a surgical excisional biopsy of the right breast lesion. Although classic lobular carcinoma in situ (LCIS) is considered a non-malignant marker of increased risk for future bilateral breast cancer rather than a true precursor lesion, finding it on a core needle biopsy (CNB) presents a specific clinical dilemma. CNB samples only a small portion of the suspicious area. Studies demonstrate that in 10% to 30% of cases where CNB yields LCIS, complete surgical excision of the lesion reveals concurrent ductal carcinoma in situ (DCIS) or invasive carcinoma that the needle missed. Because of this significant 'upgrade rate', standard clinical guidelines mandate that a core biopsy diagnosis of LCIS must be followed by an open surgical excisional biopsy to thoroughly evaluate the entire lesion and definitively rule out malignancy. Only after the excisional biopsy confirms that the lesion is purely LCIS (with no higher-grade pathology) can the patient be safely transitioned to long-term observation and chemoprevention strategies.

Step-by-Step Solution

1
Analyze the patient's presentation and initial diagnostic findings.
The patient has a new cluster of microcalcifications that yielded classic lobular carcinoma in situ (LCIS) on a stereotactic core needle biopsy.
Establishing the initial pathology and the method of tissue sampling is required to determine the next step in the clinical pathway.
2
Identify the clinical significance of finding LCIS specifically on a core needle biopsy.
Core needle biopsies only sample a fraction of the lesion. There is a 10% to 30% risk of an 'upgrade' to concurrent ductal carcinoma in situ (DCIS) or invasive cancer that was missed by the needle.
Understanding the limitations of core needle biopsies dictates whether additional tissue sampling is needed.
3
Determine the definitive next step in management.
An open surgical excisional biopsy must be performed to remove the entire area of calcifications and rule out a more advanced, concurrent malignancy before deciding on long-term management.
Complete excision provides the final, definitive pathology required to safely recommend observation or pharmacological risk reduction.

Key Concept

Management of Lobular Carcinoma In Situ (LCIS) diagnosed on core needle biopsy requires surgical excision to rule out concurrent invasive disease.
Question 13Question →

Match each distinct clinical presentation of a breast disorder to its most likely diagnosis.

Click a left item, then click its matching right item

Items

Spontaneous, unilateral bloody nipple discharge with no palpable mass and unremarkable imaging.
Erythematous, edematous breast with peau d'orange appearance that does not improve with a course of antibiotics.
Firm, rubbery, highly mobile, and well-circumscribed 2-cm breast mass in a 22-year-old woman.
Bilateral, diffuse breast nodularity associated with cyclical pain that worsens just prior to menses.
Hard, fixed, irregular breast mass associated with overlying skin dimpling and ipsilateral axillary lymphadenopathy.

Matches

Show answer & explanation

Answer

Match presentations based on unique hallmarks: bloody discharge without mass to intraductal papilloma, peau d'orange unresponsive to antibiotics to inflammatory breast cancer, highly mobile mass in young woman to fibroadenoma, cyclical nodularity to fibrocystic changes, and fixed mass with dimpling to invasive ductal carcinoma.
Each pair correctly links a pathognomonic clinical presentation with its definitive diagnosis based on patient age, symptom onset, physical exam findings (like mobility or skin changes), and response to initial management.

Step-by-Step Solution

1
Evaluate the patient presenting with bloody nipple discharge.
Matched with Intraductal papilloma.
It is the most common cause of bloody nipple discharge in the absence of a coexisting mass.
2
Assess the presentation of an erythematous breast with peau d'orange failing to resolve on antibiotics.
Matched with Inflammatory breast cancer.
Dermal lymphatic invasion causes peau d'orange, and failure to respond to antibiotics differentiates it from infectious mastitis.
3
Analyze the young female patient with a highly mobile, rubbery mass.
Matched with Fibroadenoma.
These are the classic physical examination features of this benign solid tumor.
4
Identify the cause of bilateral cyclical breast pain and diffuse nodularity.
Matched with Fibrocystic changes.
Symptoms that classically fluctuate with the menstrual cycle suggest a benign physiologic response.
5
Evaluate the patient with a hard, fixed mass and skin dimpling.
Matched with Invasive ductal carcinoma.
Skin dimpling indicates suspensory ligament involvement, which is highly suspicious for an invasive malignancy.

Key Concept

Clinical differentiation of benign and malignant breast pathology based on history and physical exam findings.
Question 14Question →

Match each clinical scenario describing a patient with a breast disorder to the most appropriate next step in management.

Click a left item, then click its matching right item

Items

A 42-year-old woman undergoes a core needle biopsy of an indeterminate mammographic density. Pathology reveals lobular carcinoma in situ (LCIS).
A 50-year-old woman undergoes an excisional biopsy of a palpable breast mass with clear margins. Pathology confirms lobular carcinoma in situ (LCIS).
A 35-year-old woman presents with spontaneous, unilateral, bloody nipple discharge. Physical examination, mammography, and ultrasound are completely normal.
A 28-year-old lactating woman presents with a 4-cm, tender, fluctuant breast mass and fever despite 3 days of appropriate oral antibiotic therapy.
A 54-year-old asymptomatic woman is found to have newly clustered pleomorphic microcalcifications in the right breast on a routine screening mammogram.

Matches

Show answer & explanation

Answer

The correct matches accurately pair specific clinical and histological presentations of breast pathology with their guideline-directed next steps in management.
Each presentation requires a highly specific intervention: LCIS on core biopsy requires excision to prevent understaging, while fully excised LCIS only needs surveillance. Pathologic discharge without imaging correlates requires duct excision. Abscesses are first managed by aspiration, and microcalcifications are sampled using stereotactic guidance.

Step-by-Step Solution

1
Evaluate the management of LCIS diagnosed via core needle biopsy.
Identify that surgical excisional biopsy is required.
Core needle biopsy may miss adjacent DCIS or invasive cancer; excisional biopsy is needed to rule out upstaging.
2
Evaluate the management of LCIS fully excised with clear margins.
Identify that surveillance and discussion of chemoprevention is the appropriate next step.
Completely excised LCIS is a risk marker, not a true malignancy, and does not require further surgery or radiation.
3
Evaluate the workup for pathologic nipple discharge with negative imaging.
Identify subareolar duct excision as the necessary intervention.
A physical sample is needed to diagnose underlying pathology (e.g., intraductal papilloma) when imaging cannot locate a target.
4
Evaluate the treatment for a lactational breast abscess.
Identify ultrasound-guided needle aspiration as first-line therapy.
Needle aspiration is preferred over incision and drainage for breast abscesses due to reduced morbidity and continued ability to breastfeed.
5
Evaluate the workup for suspicious mammographic microcalcifications.
Identify stereotactic core needle biopsy as the correct step.
Stereotactic guidance utilizes mammography to successfully target calcifications that are typically invisible on ultrasound.

Key Concept

Management of breast disorders requires differentiating the diagnostic algorithms for non-palpable imaging abnormalities, pathologic nipple discharge, breast infections, and the specific surgical implications of LCIS based on the biopsy method.
Question 15Question →

A 36-year-old woman comes to the clinic reporting spontaneous, intermittent bloody discharge from her left nipple for the past 6 weeks. She has noticed dark stains on her bra but denies breast pain, skin changes, or a palpable lump. She has no personal or family history of breast cancer. She takes no medications. Vital signs are within normal limits. Physical examination reveals no palpable breast masses, skin dimpling, or axillary lymphadenopathy. Gentle pressure applied to the periareolar area of the left breast elicits a few drops of serosanguineous discharge from a single duct. Diagnostic mammography and targeted ultrasound of the left breast show no abnormalities. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Excision of the involved breast duct

Answer

Excision of the involved breast duct is the most appropriate next step because pathologic nipple discharge requires definitive tissue evaluation, even when initial imaging is negative.
The correct answer provides the definitive diagnostic and therapeutic intervention for this patient. Pathologic nipple discharge is characterized by spontaneous, unilateral release of bloody, serous, or clear fluid from a single duct. The most common cause is a benign intraductal papilloma; however, underlying malignancies (e.g., ductal carcinoma in situ or papillary carcinoma) must be ruled out. In women age 30 and older, the initial evaluation is diagnostic mammography and targeted ultrasound. If imaging identifies a lesion, a targeted core needle biopsy is performed. However, if imaging is completely normal (as in this vignette), a blind core biopsy cannot be performed. Instead, the standard of care is surgical excision of the involved terminal duct (microdochectomy). This procedure removes the affected duct system, providing necessary tissue for histopathologic diagnosis and simultaneously resolving the bothersome discharge.

Step-by-Step Solution

1
Characterize the nipple discharge based on the clinical presentation.
The discharge is unilateral, spontaneous, bloody (serosanguineous), and originates from a single duct.
These features define 'pathologic' nipple discharge, which carries a higher risk of underlying malignancy compared to bilateral, milky 'physiologic' discharge.
2
Determine the appropriate initial diagnostic pathway for pathologic nipple discharge in a patient over 30 years old.
The patient correctly underwent bilateral diagnostic mammography and targeted ultrasound.
Imaging is required to identify any occult masses, structural abnormalities, or suspicious microcalcifications that could represent cancer.
3
Determine the next management step when initial imaging is completely negative.
Surgical excision of the involved terminal duct (microdochectomy).
Negative imaging does not rule out malignancy in the presence of pathologic discharge. Since there is no target for a core needle biopsy, duct excision is required for definitive histologic diagnosis.

Key Concept

Evaluation and management of pathologic nipple discharge with negative imaging
Estimated Time:2m 0s
Question 16Question →

A 33-year-old woman comes to the office after noticing a firm, painless lump in her left breast 2 weeks ago. Physical examination reveals a 2.5-cm, hard, nonmobile mass in the upper outer quadrant of the left breast without overlying skin changes. There is no palpable axillary lymphadenopathy. Assuming the mass is highly suspicious for early-stage invasive breast carcinoma, arrange the following steps in the most appropriate chronological sequence for her standard diagnostic workup and management.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence begins with imaging (mammography and ultrasound), followed by core needle biopsy for tissue diagnosis. Next, the tissue undergoes receptor testing. Once fully characterized, the patient undergoes breast-conserving surgery, which is then followed by adjuvant radiation therapy.
The standard protocol for evaluating and treating a suspicious breast mass in a woman aged 30 or older follows a stepwise approach: initial non-invasive imaging (mammography and ultrasound) to characterize the lesion, followed by a minimally invasive core needle biopsy for histologic diagnosis. Once confirmed as cancer, the tissue undergoes receptor profiling to guide overall therapy. Only after this comprehensive workup does the patient undergo definitive local surgical treatment, such as a lumpectomy with a sentinel lymph node biopsy. Because breast-conserving surgery leaves breast tissue behind, it must be followed by adjuvant whole-breast radiation therapy to minimize the risk of local recurrence.

Step-by-Step Solution

1
Order bilateral diagnostic mammography and targeted ultrasound.
Characterization of the breast mass and assessment of the contralateral breast and axilla.
This is the required first step in women aged 30 and older with a palpable breast mass.
2
Perform an image-guided core needle biopsy of the lesion.
Obtain a tissue sample for histological diagnosis.
A definitive tissue diagnosis is required to confirm malignancy before any surgical intervention.
3
Send the biopsy specimen for immunohistochemical receptor testing.
Determination of estrogen receptor, progesterone receptor, and HER2 status.
Receptor status dictates the need for targeted neoadjuvant or adjuvant systemic therapies and provides prognostic information.
4
Perform breast-conserving surgery (lumpectomy) with sentinel lymph node biopsy.
Removal of the primary tumor with negative margins and axillary staging.
This provides definitive local surgical control for early-stage, localized breast cancer.
5
Administer adjuvant whole-breast radiation therapy.
Treatment of the remaining breast tissue.
Radiation is mandatory after breast-conserving surgery to reduce the risk of local tumor recurrence.

Key Concept

The chronological sequence for evaluating and managing a suspicious breast mass in a woman aged 30 or older involves non-invasive imaging, minimally invasive tissue sampling, comprehensive pathological profiling, local surgical control, and finally adjuvant radiation.
Question 17Question →

An asymptomatic 5656-year-old female presents to the clinic to discuss her recent imaging and biopsy results. During a routine health maintenance visit last month, a bilateral mammogram was ordered which demonstrated a highly suspicious 1.81.8-cm stellate density with clustered, fine linear branching calcifications in the upper outer quadrant of her left breast (BI-RADS 55). A subsequent image-guided stereotactic core needle biopsy of the lesion was performed. The histopathology report describes classic lobular carcinoma in situ (LCIS) without evidence of invasive malignancy, atypical ductal hyperplasia, or ductal carcinoma in situ. The patient has a history of hypertension and diet-controlled type 2 diabetes mellitus. Menopause occurred at age 5151. She currently takes lisinopril. Vital signs are within normal limits. Breast examination reveals symmetrical breasts with no skin dimpling, nipple retraction, or palpable masses. There is no cervical, supraclavicular, or axillary adenopathy. Which of the following is the most appropriate next action for this patient?

Show answer & explanation

Answer: Image-guided diagnostic surgical excision of the left breast lesion

Answer

The correct action is an image-guided diagnostic surgical excision of the left breast lesion to definitively evaluate the undiagnosed radiologic abnormality.
The most appropriate next step for this patient is an image-guided diagnostic surgical excision of the breast lesion. This scenario is a classic presentation of radiologic-pathologic discordance. The patient has a highly suspicious BI-RADS 55 lesion (a stellate density with fine linear branching calcifications), which carries a greater than 95%95\% probability of malignancy. However, the core needle biopsy returned classic lobular carcinoma in situ (LCIS). LCIS is typically an incidental, non-palpable microscopic finding that does not form stellate masses or linear calcifications on mammography. Because the histologic findings do not explain the highly suspicious imaging features, the biopsy is discordant. A discordant core biopsy result strongly suggests a sampling error where the actual malignant lesion was missed. Therefore, the entire suspicious area must be surgically excised to definitively identify the suspected underlying invasive carcinoma.

Step-by-Step Solution

1
Analyze the mammography findings to determine the pre-test probability of malignancy.
The imaging shows a 1.81.8-cm stellate density with linear branching calcifications (BI-RADS 55), which indicates a >95%>95\% likelihood of invasive carcinoma or high-grade ductal carcinoma in situ.
Establishing the level of radiologic suspicion is required to interpret subsequent biopsy results accurately.
2
Evaluate the histopathologic diagnosis from the core needle biopsy.
The biopsy returned classic lobular carcinoma in situ (LCIS).
Pathology results must be correlated with imaging to ensure the targeted lesion was successfully and accurately sampled.
3
Compare the radiologic features with the histopathologic findings to determine concordance.
LCIS is typically an incidental microscopic finding that does not form a stellate mass or malignant-appearing calcifications. Therefore, the biopsy results do not explain the imaging findings.
If pathology does not explain the imaging, radiologic-pathologic discordance is present, indicating a likely sampling error by the biopsy needle.
4
Determine the appropriate management for radiologic-pathologic discordance.
The most appropriate next step is a diagnostic surgical excision (excisional biopsy) of the targeted area.
Complete removal of the lesion is necessary to locate the underlying invasive carcinoma or DCIS that the core needle missed.

Key Concept

Radiologic-pathologic discordance following a core needle breast biopsy requires a diagnostic surgical excision to definitively rule out a missed malignancy.
Question 18Question →

A 44-year-old woman comes to the clinic after noticing a new lump in her right breast 2 weeks ago. She performs intermittent breast self-examinations and has no family history of breast or ovarian cancer. Her medical history is significant for primary hypothyroidism, for which she takes levothyroxine. Menarche was at age 12, and she has regular menstrual cycles. She had a routine screening mammogram 4 months ago, which was reported as normal with heterogeneously dense breast tissue (BI-RADS 1). Vital signs are within normal limits. On physical examination, there is a 2.5-cm, firm, non-tender, and freely mobile mass in the upper outer quadrant of the right breast. There are no overlying skin changes, nipple retraction, or nipple discharge. There is no palpable cervical, supraclavicular, or axillary lymphadenopathy. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Diagnostic mammography and targeted ultrasound

Answer

The most appropriate next step is diagnostic mammography and targeted ultrasound.
The correct answer is diagnostic mammography and targeted ultrasound. For any woman aged 30 or older who presents with a newly identified palpable breast mass, standard clinical guidelines dictate that both targeted ultrasound and diagnostic mammography must be performed. A screening mammogram is designed for asymptomatic patients and utilizes only two standard views (craniocaudal and mediolateral oblique). In contrast, a diagnostic mammogram employs additional, specialized views (such as spot compression or magnification) specifically focused on the palpable abnormality. Furthermore, screening mammography has a false-negative rate of up to 15%, which is even higher in patients with dense breast tissue. Therefore, a recent 'normal' screening mammogram provides false reassurance and does not bypass the need for a complete diagnostic imaging workup when a new focal finding arises.

Step-by-Step Solution

1
Identify the patient's demographic and clinical presentation.
The patient is a 44-year-old woman presenting with a new, 2.5-cm, firm, palpable breast mass.
Age and the presence of a focal palpable mass are the primary determinants of the initial diagnostic pathway in breast pathology.
2
Evaluate the significance of the previous imaging.
The screening mammogram from 4 months ago was normal, but the patient now has a new, clinically apparent mass.
Screening mammograms consist of only two standard views per breast and can miss up to 15% of breast cancers, particularly in patients with dense breast tissue. A prior negative screening mammogram does not preclude the need for a full diagnostic workup of a new symptom.
3
Apply the age-based algorithm for a palpable breast mass.
Because the patient is ≥ 30 years old, the standard of care requires both a targeted ultrasound and a diagnostic mammogram.
Diagnostic mammography includes specialized views (e.g., spot compression, magnification) tailored to the palpable area and evaluates the rest of the breast tissue. Ultrasound characterizes the mass (cystic vs. solid) and guides potential biopsy. Both are mandatory in this age group.

Key Concept

In women aged 30 years or older presenting with a new palpable breast mass, the most appropriate initial evaluation is diagnostic mammography and targeted ultrasound, even if a recent screening mammogram was normal.
Question 19Question →

A 32-year-old primigravid woman at 8 weeks gestation presents to the clinic after noticing a firm, painless lump in her right breast. Examination reveals a 4-cm, hard, immobile mass in the upper outer quadrant with clinically positive axillary lymphadenopathy. She strongly desires to continue the pregnancy and wants to pursue comprehensive treatment to maximize her survival. Assuming the diagnostic workup ultimately confirms invasive ductal carcinoma, arrange the following management steps in the strictly indicated chronological order for this specific patient, from initial evaluation through to postpartum care.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is: 1) Targeted ultrasound, 2) Core needle biopsy, 3) Mastectomy, 4) Chemotherapy, 5) Radiotherapy.
The sequence reflects the mandatory safety constraints of pregnancy. The workup begins with ultrasound (safest imaging) followed by core biopsy (required for diagnosis). Because the patient is only at 8 weeks gestation (first trimester), chemotherapy cannot be given yet. Therefore, surgery (which is safe under general anesthesia in all trimesters) must precede chemotherapy. Chemotherapy is then initiated once the second trimester is reached. Finally, radiation therapy is absolutely contraindicated at all stages of pregnancy and must be placed last, in the postpartum period.

Step-by-Step Solution

1
Determine the initial imaging modality.
Targeted ultrasound.
In pregnant women of any age, ultrasound is the preferred initial imaging test for palpable breast masses to eliminate fetal radiation risk.
2
Establish a tissue diagnosis.
Core needle biopsy.
Imaging alone is insufficient to diagnose malignancy; core biopsy under local anesthesia is safe and strictly required before definitive treatment.
3
Select the safest initial definitive therapy for a first-trimester patient.
Mastectomy with axillary staging.
At 8 weeks gestation, chemotherapy is highly teratogenic. Surgery is the only safe major therapeutic intervention in the first trimester. Mastectomy is often chosen because breast-conserving therapy would require radiation, which cannot be safely delivered or delayed for 7+ months.
4
Determine the timing of systemic therapy.
Anthracycline-based chemotherapy in the second trimester.
Chemotherapy can be safely administered during the second and third trimesters, making it the next logical step after the patient recovers from surgery and enters the second trimester.
5
Determine the timing of radiation therapy.
Adjuvant radiotherapy postpartum.
Therapeutic radiation poses severe risks of fetal anomalies and childhood cancer regardless of trimester; thus, it is universally delayed until after delivery.

Key Concept

The management of breast cancer during pregnancy requires strict adherence to trimester-based contraindications: ultrasound and biopsy are safe anytime, surgery is safe anytime (but is the mandatory first therapeutic step in the 1st trimester), chemotherapy is contraindicated in the 1st trimester but safe in the 2nd/3rd, and radiation is contraindicated until postpartum.
Question 20Question →

A 24-year-old woman, gravida 1, para 1, comes to the emergency department 4 weeks postpartum due to a 3-day history of a painful, swollen right breast. She is exclusively breastfeeding her infant. She reports subjective fevers, chills, and fatigue. Her temperature is 38.8∘C38.8^\circ\text{C} (101.8∘F101.8^\circ\text{F}), blood pressure is 110/70 mmHg110/70\text{ mmHg}, and pulse is 102/min102/\text{min}. Physical examination of the right breast reveals a 4-cm area of marked erythema, induration, and tenderness in the lower outer quadrant. Careful palpation of this area reveals a distinct, centrally fluctuant mass. There is no overlying skin retraction or purulent nipple discharge. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Targeted ultrasound of the right breast

Answer

Targeted ultrasound of the right breast
The patient's presentation of fever, localized breast erythema, and a fluctuant mass in the setting of lactation is highly suggestive of a breast abscess. The most appropriate next step in management is a targeted ultrasound of the breast. Ultrasound is the imaging modality of choice to confirm the presence of a fluid collection, differentiate it from severe mastitis without an abscess, and directly guide the first-line intervention, which is typically image-guided needle aspiration.

Step-by-Step Solution

1
Analyze the patient's clinical presentation.
The patient is a lactating postpartum woman with fever, localized breast erythema, tenderness, and a palpable fluctuant mass.
Identifying these classic signs differentiates complicated mastitis (abscess) from simple lactational mastitis.
2
Determine the primary diagnosis.
The presence of a fluctuant mass in the setting of mastitis strongly suggests a breast abscess.
Fluctuance indicates a localized collection of purulent fluid that requires mechanical intervention.
3
Select the most appropriate next step in management.
Targeted breast ultrasound is indicated.
Ultrasound confirms the presence of an abscess, evaluates its loculations, and provides guidance for first-line treatment, which is minimally invasive needle aspiration.

Key Concept

Diagnosis and management of lactational breast abscess
Page 1 / 4Next
Breast Disorders Practice Questions — USMLE Step 2 CK | Examkin